Control intervention matters: an important but often ignored factor affecting clinical heterogeneity in meta-analyses of acupuncture trials

Lund I Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med 2006; 24(1): 13–15.

Pieper D Antoine S-L Mathes T , et al. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol 2014; 67(4): 368–375.

Howick J Webster RK Rees JL , et al. TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls. PLoS Med 2020; 17(9): e1003294.

U.S. Food and Drug Administration. Clinical studies section of labeling for human prescription drug and biological products: content and format. Silver Spring, MD: U.S. Food and Drug Administration, 2012.

Kim T-H Kang JW Lee MS. What is lost in the acupuncture trial when using a sham intervention? Acupunct Med 2017; 35(5): 384–386.